FCUV · XBRL financial data
Focus Universal financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (FCUV's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1,679 | 1,434 | 354 | 1,052 | 398 | 255 |
| Cost of revenue | 1,395 | 1,137 | 331 | 958 | 388 | 290 |
| Gross profit | 284 | 297 | 23 | 94 | 10 | (35) |
| Research and development | 257 | 220 | 1,060 | 1,387 | 1,382 | 920 |
| General and administrative | 1,269 | 1,363 | 2,074 | 1,741 | 2,116 | 2,075 |
| Total operating expenses | 2,988 | 4,451 | 5,228 | 5,057 | 6,210 | 4,858 |
| Operating income (loss) | (2,704) | (3,017) | (5,206) | (4,963) | (6,200) | (4,893) |
| Other income (expense) | 171 | 196 | 14 | 78 | 60 | 37 |
| Income tax expense (benefit) | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income (loss) | (2,537) | (3,221) | (4,927) | (4,718) | (3,200) | (4,788) |
| Earnings per share, basic USD per share | — | (0.08) | (0.11) | (0.08) | (0.48) | (7.07) |
| Earnings per share, diluted USD per share | — | (0.08) | (0.11) | (0.08) | (0.48) | (7.07) |
| Weighted average shares, basic thousands of shares | — | 41,716 | 43,413 | 60,315 | 6,714 | 742 |
| Weighted average shares, diluted thousands of shares | — | 41,716 | 43,413 | 60,315 | 6,714 | 742 |
- † Share count changed about 1/9 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/7 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (FCUV's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 583 | 8,679 | 4,343 | 428 | 3,589 | 7,935 |
| Accounts receivable | 191 | 177 | 78 | 164 | 6 | 7 |
| Inventory | 42 | 23 | 104 | 282 | 126 | 100 |
| Total current assets | 1,008 | 9,214 | 4,808 | 1,028 | 3,846 | 8,647 |
| Property and equipment, net | 4,493 | 4,353 | 4,229 | 4,081 | 60 | 67 |
| Right-of-use asset | 87 | 420 | 253 | 201 | 108 | 13 |
| Total assets | 5,593 | 14,022 | 9,323 | 5,334 | 4,080 | 8,886 |
| Total current liabilities | 528 | 571 | 1,387 | 1,658 | 877 | 366 |
| Lease liability, non-current | 41 | 302 | 166 | 119 | 8 | 0 |
| Total liabilities | 789 | 900 | 1,566 | 1,788 | 885 | 366 |
| Accumulated deficit | (9,716) | (12,937) | (17,864) | (22,582) | (25,782) | (31,023) |
| Total stockholders' equity | 4,805 | 13,122 | 7,758 | 3,546 | 3,195 | 2,573 |
| Total liabilities and equity | 5,593 | 14,022 | 9,323 | 5,334 | 4,080 | 8,886 |
| Common shares outstanding (cover page) thousands of shares | 40,960 | 43,260 | 43,230 | 64,772 | 7,114 | 1,025 |
- † Share count changed about 1/9 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/7 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (FCUV's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (2,537) | (3,221) | (4,927) | (4,718) | (3,200) | (4,788) |
| Stock-based compensation | 48 | 48 | 0 | — | — | — |
| Net cash from operating activities | (1,955) | (2,228) | (2,958) | (3,529) | (4,657) | (5,103) |
| Purchases of property and equipment | 1 | 23 | 42 | 21 | 19 | 28 |
| Net cash from investing activities | (1) | (23) | (211) | 54 | 7,127 | (186) |
| Share repurchases | — | 0 | 1,000 | 1,434 | 670 | 494 |
| Net cash from financing activities | 347 | 10,347 | (1,159) | (434) | 706 | 9,648 |
| Net change in cash | (1,610) | 8,095 | (4,335) | (3,915) | 3,161 | 4,346 |
- † Share count changed about 1/9 in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/7 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 3823 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3823 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Focus Universal | 1,600 | 675 | (741)* | 702,745 | 2.2 quarters | 10-QJun 30, 2026 |
| Precipio | 3,075 | 7,021 | 660* | 1.8M | — | 10-QJun 30, 2026 |
| Bionano Genomics | 3,730 | 8,171 | (4,670)* | 11.8M | 2.1 quarters | 10-QJun 30, 2026 |
| Harvard Bioscience | 6,503 | 22,727 | 325* | 4.6M | — | 10-QJun 30, 2026 |
| MultiSensor AI Holdings | 21,005 | 1,695 | (2,392)* | 2.2M | 8.8 quarters | 10-QJun 30, 2026 |
| Optex Systems Holdings | 6,175 | 9,729 | 2,323* | 7.0M | — | 10-QJun 28, 2026 |
| Syntec Optics Holdings | 14,047 | 8,274 | (299)* | 40.3M | 47.0 quarters | 10-QJun 30, 2026 |
| Data I/O | 10,843 | 5,149 | (2,939)* | 10.4M | 3.7 quarters | 10-QJun 30, 2026 |
| ClearSign Technologies | 9,889 | not reported | (1,236)* | 6.8M | 8.0 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.